Tradestie Institutional Equity Comparison Engine
COCP vs DARE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DARE Overall Edge
DARE Captures Institutional Edge (2โ1 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Dare Bioscience, Inc. Common Stock (DARE) driven by superior Valuation, Growth & Margin while COCP counters with relative strength in Momentum & Technical. Fundamentally, COCP trades at N/M Forward P/E with -3063.6% operating margin (+26.9% YoY revenue) versus DARE at 1.3x Forward P/E and -813.4% operating margin (+499.6% YoY). In options structure, COCP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DARE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
DARE
COCP N/M vs DARE 1.3x Fwd P/E
Growth & Margin Winner
DARE
Op Margin -3063.6% vs -813.4% ยท YoY +26.9% vs +499.6%
Momentum & Technical Winner
COCP
1Y -3.0% vs -67.0% ยท 52W Pos 19% vs 1%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
COCP
NASDAQ
Cocrystal Pharma, Inc. Common Stock
Pharmaceutical Preparations
$1.00
+1.98% 1D
Market Cap
$19.6M
1M Return
-2.01%
1Y Return
-2.96%
Forward P/E
N/M
Unified AI Score
47.1 / 100
HOLD
Tech 51.0
Fund 48.0
Flow 50.0
Mom 54.0
DARE
NASDAQ
Dare Bioscience, Inc. Common Stock
Pharmaceutical Preparations
$0.62
-5.13% 1D
Market Cap
$12.7M
1M Return
-13.93%
1Y Return
-67.0%
Forward P/E
1.3x
Unified AI Score
41.3 / 100
SELL
Tech 39.0
Fund 52.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
COCP -2.96%
DARE -67.0%
Spread: +64.04 pp (COCP Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | COCP Revenue | DARE Revenue | COCP Op. Margin | DARE Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2014 | N/A | $0M | N/A | -29177.5% | DARE |
| FY2016 | N/A | $0M | N/A | -82.3% | DARE |
| FY2019 | $10M | N/A | -737.4% | N/A | COCP |
| FY2020 | $0M | N/A | -476.0% | N/A | COCP |
| FY2022 | N/A | $10M | N/A | -313.9% | DARE |
| FY2023 | N/A | $0M | N/A | -1101.9% | DARE |
| FY2024 | N/A | $0M | N/A | -239692.2% | DARE |
| FY2025 | N/A | $0M | N/A | -1315.5% | DARE |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | COCP | DARE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $19.6M | $12.7M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | 1.3x | Lower Multiple | DARE |
| Forward P/E Ratio Valuation | N/M | 1.3x | Lower Multiple | DARE |
| Revenue Growth (YoY) Growth | +26.9% | +499.6% | Higher Growth | DARE |
| Operating Margin (TTM) Profitability | -3063.6% | -813.4% | Higher Margin | DARE |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -311.7% | -2543.1% | Higher ROE | COCP |
| 52-Week Range Position Momentum | 19% ($1โ$2) | 1% ($1โ$4) | Stronger Trend | COCP |
| Beta / 30D Volatility Risk Regime | 1.04ฮฒ ยท 54% Vol | 1.38ฮฒ ยท 60% Vol | Lower Realized Risk | COCP |
| Unified Institutional Score Composite Signal | 47.1 / 100 (HOLD) | 41.3 / 100 (SELL) | Higher Composite | COCP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full COCP vs DARE Buy Guide
COCP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
DARE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither COCP nor DARE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.